Literature DB >> 6668555

Influence of volume shifts on drug binding during equilibrium dialysis: correction and attenuation.

J J Lima, J J MacKichan, N Libertin, J Sabino.   

Abstract

A time-dependent volume shift from buffer to plasma, which occurs during equilibrium dialysis, decreased the protein binding of disopyramide and its capacity constant, and had no effect on the binding association constant. The volume-dependent decrease in disopyramidine binding may be corrected for by use of a derived equation. Inclusion of dextran, 2.5% (w/v), and use of a thick, low molecular weight cutoff membrane was the most effective technique in attenuating the volume shift. The plasma (serum) protein binding of the basic drugs lidocaine, disopyramide, propranolol, and diazepam was decreased when protein was diluted to 88% or less of its undiluted concentration as a consequence of the volume shift. The protein binding of clofibrate, a highly bound acid drug, was more sensitive to volume shifts than the four basic drugs. Correction of drug binding for volume shifts was reasonably successful for most drugs. The highest binding measured for all drugs was associated with the lowest volume shift.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6668555     DOI: 10.1007/bf01062207

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  7 in total

1.  A statistical method for the estimation of binding parameters in a complex system.

Authors:  R L Priore; H E Rosenthal
Journal:  Anal Biochem       Date:  1976-01       Impact factor: 3.365

2.  A graphic method for the determination and presentation of binding parameters in a complex system.

Authors:  H E Rosenthal
Journal:  Anal Biochem       Date:  1967-09       Impact factor: 3.365

3.  Interpretation of protein-drug interaction through fraction bound and relative contribution of secondary sites.

Authors:  R F Mais; S Keresztes-Nagy; J F Zaroslinski; Y T Oester
Journal:  J Pharm Sci       Date:  1974-09       Impact factor: 3.534

4.  Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration.

Authors:  H Kurz; H Trunk; B Weitz
Journal:  Arzneimittelforschung       Date:  1977-07

5.  Volume shifts and protein binding estimates using equilibrium dialysis: application to prednisolone binding in humans.

Authors:  T N Tozer; J G Gambertoglio; D E Furst; D S Avery; N H Holford
Journal:  J Pharm Sci       Date:  1983-12       Impact factor: 3.534

6.  Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics.

Authors:  J J Lima; H Boudoulas; M Blanford
Journal:  J Pharmacol Exp Ther       Date:  1981-12       Impact factor: 4.030

7.  Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis.

Authors:  F D Boudinot; W J Jusko
Journal:  J Pharm Sci       Date:  1984-06       Impact factor: 3.534

  7 in total
  9 in total

1.  Pharmacokinetics and safety assessments of high-dose and 4-week treatment with S-3304, a novel matrix metalloproteinase inhibitor, in healthy volunteers.

Authors:  Timothy G K Mant; Daniel Bradford; Dipti M Amin; Jaya Pisupati; Yoshikazu Kambayashi; Yoshitaka Yano; Kazushige Tanaka; Takuko Yamada-Sawada
Journal:  Br J Clin Pharmacol       Date:  2006-10-31       Impact factor: 4.335

2.  Polymorphic flecainide disposition under conditions of uncontrolled urine flow and pH.

Authors:  A S Gross; G Mikus; C Fischer; M Eichelbaum
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  Measurement and analysis of unbound drug concentrations.

Authors:  J D Wright; F D Boudinot; M R Ujhelyi
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

4.  Evaluation of equilibrium dialysis volume shifts: a comment.

Authors:  S H Curry; O Y Hu
Journal:  J Pharmacokinet Biopharm       Date:  1984-08

5.  Monitoring of the free concentration of cyclosporine in plasma in man.

Authors:  A Lindholm
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  Free plasma concentrations of piroxicam in patients with osteoarthritis: relation to age, sex and efficacy.

Authors:  O Hundal; H E Rugstad
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

Review 7.  Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.

Authors:  J H Lin; D M Cocchetto; D E Duggan
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

8.  Determinants of carbamazepine and carbamazepine 10,11-epoxide binding to serum protein, albumin and alpha 1-acid glycoprotein.

Authors:  J J MacKichan; E M Zola
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

9.  Disopyramide pharmacokinetics and bioavailability following the simultaneous administration of disopyramide and 14C-disopyramide.

Authors:  J J Lima; D B Haughey; C V Leier
Journal:  J Pharmacokinet Biopharm       Date:  1984-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.